The new method will enable quick and easy detection of any cancer from any type of body tissue such as blood or biopsy.
The study is published today in the journal Nature Communications.
However, the cancer test has not yet been tested on all types of the disease.
Trau explained: "It seems to be a general feature for all cancer".
It had been hard to find a simple signature that was distinct from healthy cells and common to all cancers.
Healthy cells ensure they function properly by patterning their DNA with molecules called methyl groups.
"In healthy cells, these methyl groups are spread out across the genome, but the genomes of cancer cells are essentially barren except for intense clusters of methyl groups at very specific locations".
"Virtually every piece of cancer DNA we examined had this highly predictable pattern", stated Trau.
It is created to detect cancer from blood or biopsy tissue by analysing methyl group changes at the genomic level.
Piranha Plant Super Smash Bros Ultimate pre order bonus
No one saw it coming, mostly because Persona 5 isn't even available on a Nintendo platform, but that could be changing. Smash Ultimate players who opted to buy the digital version of the game won't have to register the game at all.
FINISH HIM!! Mortal Kombat 11 Announced and Dated for Release
Preorders are open now and necessary if you want access to villain Shao Kahn and the game beta. The promo for Mortal Kombat 11 is out and the gaming world is going insane .
Prince William and Kate thank British troops in Cyprus
Meanwhile, the Duke and Duchess of Cambridge hosted a Christmas party for Royal Air Force families on Tuesday. I still see her from time to time had seen only in jeans.
But Dr. Nissenblatt says that the test could still prove to be useful.
When the researchers tested this on blood or biopsy samples of cancer patients they found this to be accurate in 90% of cases.
"You can compare that with some of our frontline cancer detection techniques", he said.
A ten-minute test for all kinds of cancer is on the horizon after scientists developed a way to detect traces of the disease in a patient's bloodstream.
Although the research is still in its early stages, and needs to be validated in thousands of patients, they are searching for a commercial partner to develop the test.
Lead author Dr Abu Ali Ibn Sina, from the University of Queensland's Centre for Personalised Nanomedicine, said: 'This discovery could be a game-changer in point of care cancer diagnostics'.
As consumers try to digest this news, I think it's important to think about those numbers.
This test is still in development, and it draws a radical new approach to cancer detection that could make routine screening a straightforward procedure for doctors.
"Like all good science, it raises a lot more questions", she said. Because cancer is uncommon, it is more important to prevent false diagnoses, he said. The only way to find out if there are risky cells in our bodies is by running periodically tests and going to see the doctor as soon as we are experiencing unusual health issues.
"We certainly don't know yet whether it's the Holy Grail for all cancer diagnostics".